8352ab43-figure-01 (8352ab43 Figure 01)
Amlodipine Besylate
Product Images NDC 68151-0995
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 68151-0995). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
8352ab43-figure-02 (8352ab43 Figure 02)
This appears to be a graph related to a medical study, showing the event rate over time in months. There is a P-value of 0.003 and a Hazard Ratio of 0.691 mentioned. The graph may be related to a comparison of two treatments, one of which may involve the medication Amiodipine. However, due to the lack of context and incomplete text, it is difficult to provide a more specific description.*
8352ab43-figure-03 (8352ab43 Figure 03)
Label Image (Lbl681510995)
This is a description of a medication called Amlodipine Besylate, presented as a 10 mg tablet. The manufacturer specified is InvaGen. The rest of the information contains a date (07/14), a code (143m2) and a reference to a prescription (PDM:0995).*
Table1 (Tab1)
This appears to be a table displaying the effects of different dosages of Amlodipine on patients. The symptoms reported include Edema, Dizziness, Flushing, and Palpitation, and are measured in percentages. The dosage levels evaluated are 2.5mg, 5mg, and 10mg, with sample sizes (N) for each dosage level listed. The results suggest that higher doses of Amlodipine correspond to higher incidences of symptoms. The placebo group had the lowest percentage of reported symptoms overall.*
Table2 (Tab2)
This is a comparison between the occurrence of various side effects in people taking a drug called "amlodipine besylate tablets" versus those taking a placebo (an inactive substance that looks like the actual drug). The number of people studied in each group is shown in parentheses. The side effects reported include fatigue, nausea, abdominal pain, and somnolence (feeling drowsy or sleepy).*
Table3 (Tab3)
This is a list of side effects associated with Amlodipine besylate tablets reported in a clinical study. The side effects include edema, flushing, palpitations, and somnolence. The percentage of males and females who experienced each side effect is provided for both the treatment group (N=1218) and the placebo group (N=914).*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
